You are here: Industry Insights > Market News > CK Ranganathan elected as Chairman of CII-SR; Suchitra K Ella is deputy Chairperson

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Sulopenem CAS:120788-07-0

Sulopenem etzadroxil CAS:1000296-70-7

Pimobendan CAS:74150-27-9

ERDAFITINIB CAS:1346242-81-6

lenvatinib Mesylate CAS:857890-39-2

Dacomitinib

CK Ranganathan elected as Chairman of CII-SR; Suchitra K Ella is deputy Chairperson

expresspharmaMarch 08, 2021

Tag: CII , Suchitra K Ella , CK Ranganathan

Favorites

C K Ranganathan, industrialist and Chairman of CavinKare has been elected chairman of the Confederation of Indian Industry (CII), Southern Region, for 2021-22. Suchitra K Ella, Co-founder of Bharat Biotech International was elected as deputy chairperson.

Ranganathan has been associated with the trade body in various capacities, including the deputy chairman of CII, SR and head of CII Tamil Nadu council and Foodpro 2017.

Ella was the past chairperson of CII Andhra Pradesh and also the national council member and the past national chairwoman of CII IWN (Indian Women Network) from 2015-18.

Previous:Alniche has planned to enter contract manufacturing through EffiKasia Lifesciences

Next:Aarti Speciality Chemicals gets approval under Pharma PLI Scheme

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

CK Ranganathan elected as Chairman of CII-SR; Suchitra K Ella is deputy Chairperson | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

CK Ranganathan elected as Chairman of CII-SR; Suchitra K Ella is deputy Chairperson

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may like
More>>

CK Ranganathan elected as Chairman of CII-SR; Suchitra K Ella is deputy Chairperson

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>